Literature DB >> 15189035

Structure-activity relationships at monoamine transporters for a series of N-substituted 3alpha-(bis[4-fluorophenyl]methoxy)tropanes: comparative molecular field analysis, synthesis, and pharmacological evaluation.

Santosh S Kulkarni1, Peter Grundt, Theresa Kopajtic, Jonathan L Katz, Amy Hauck Newman.   

Abstract

The development of structure-activity relationships (SAR) with divergent classes of monoamine transporter ligands and comparison of their effects in animal models of cocaine abuse have provided insight into the complex relationship among structure, binding profiles, and behavioral activity. Many 3alpha-(diphenylmethoxy)tropane (benztropine) analogues are potent dopamine uptake inhibitors but exhibit behavioral profiles that differ from those of cocaine and other compounds in this class. One of the most potent and dopamine transporter (DAT) selective N-substituted benztropine analogues (N-(4-phenyl-n-butyl)-3alpha-(bis[4-fluorophenyl]methoxy)tropane, 1c) is devoid of cocaine-like behaviors in rodent models but is also highly lipophilic (cLogD = 5.01), which compromises its water solubility and may adversely affect its pharmacokinetic properties. To further explore the SAR in this series and ultimately to design dopamine uptake inhibitors with favorable lipophilicities for drug development, a comparative molecular field analysis (CoMFA) was performed on a set of benztropine analogues previously synthesized in our laboratory. The CoMFA field analysis on the statistically significant (r2(cv) = 0.632; r2(ncv) = 0.917) models provided valuable insight into the structural features required for optimal binding to the DAT, which was used to design a series of novel benztropine analogues with heteroatom substitutions at the tropane N-8. These compounds were evaluated for binding at DAT, serotonin (SERT) and norepinephrine (NET) transporters, and muscarinic M1 receptors in rat brain. Inhibition of [3H]DA uptake in synaptosomes was also evaluated. Most of the analogues showed high DAT affinity (12-50 nM), selectivity (10- to 120-fold), potent inhibition of dopamine uptake, and lower lipophilicities as predicted by cLogD values.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15189035     DOI: 10.1021/jm030646c

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  13 in total

1.  Singular value decomposition analysis of the torsional angles of dopamine reuptake inhibitor GBR 12909 analogs: effect of force field and charges.

Authors:  Deepangi Pandit; Anna Fiorentino; Supreet Bindra; Carol A Venanzi
Journal:  J Mol Model       Date:  2010-09-14       Impact factor: 1.810

2.  Hierarchical clustering analysis of flexible GBR 12909 dialkyl piperazine and piperidine analogs.

Authors:  Kathleen M Gilbert; Carol A Venanzi
Journal:  J Comput Aided Mol Des       Date:  2006-07-20       Impact factor: 3.686

3.  Structure-Activity Relationships at the Monoamine Transporters for a Novel Series of Modafinil (2-[(diphenylmethyl)sulfinyl]acetamide) Analogues.

Authors:  Jianjing Cao; Thomas E Prisinzano; Oluyomi M Okunola; Theresa Kopajtic; Matthew Shook; Jonathan L Katz; Amy Hauck Newman
Journal:  ACS Med Chem Lett       Date:  2010-10-10       Impact factor: 4.345

4.  Conformational analysis of methylphenidate: comparison of molecular orbital and molecular mechanics methods.

Authors:  Kathleen M Gilbert; William J Skawinski; Milind Misra; Kristina A Paris; Neelam H Naik; Ronald A Buono; Howard M Deutsch; Carol A Venanzi
Journal:  J Comput Aided Mol Des       Date:  2004-11       Impact factor: 3.686

5.  N-substituted benztropine analogs: selective dopamine transporter ligands with a fast onset of action and minimal cocaine-like behavioral effects.

Authors:  Su-Min Li; Theresa A Kopajtic; Matthew J O'Callaghan; Gregory E Agoston; Jianjing Cao; Amy Hauck Newman; Jonathan L Katz
Journal:  J Pharmacol Exp Ther       Date:  2010-11-18       Impact factor: 4.030

6.  DAT/SERT selectivity of flexible GBR 12909 analogs modeled using 3D-QSAR methods.

Authors:  Kathleen M Gilbert; Terrence L Boos; Christina M Dersch; Elisabeth Greiner; Arthur E Jacobson; David Lewis; Dorota Matecka; Thomas E Prisinzano; Ying Zhang; Richard B Rothman; Kenner C Rice; Carol A Venanzi
Journal:  Bioorg Med Chem       Date:  2006-10-01       Impact factor: 3.641

Review 7.  Dopamine transport inhibitors based on GBR12909 and benztropine as potential medications to treat cocaine addiction.

Authors:  Richard B Rothman; Michael H Baumann; Thomas E Prisinzano; Amy Hauck Newman
Journal:  Biochem Pharmacol       Date:  2007-08-09       Impact factor: 5.858

8.  Synthesis and monoamine transporter affinity of 3alpha-arylmethoxy-3beta-arylnortropanes.

Authors:  Harneet Kaur; Sari Izenwasser; Abha Verma; Dean Wade; Amy Housman; Edwin D Stevens; David L Mobley; Mark L Trudell
Journal:  Bioorg Med Chem Lett       Date:  2009-10-23       Impact factor: 2.823

9.  Comparative structure-activity relationships of benztropine analogues at the dopamine transporter and histamine H(1) receptors.

Authors:  Santosh S Kulkarni; Theresa A Kopajtic; Jonathan L Katz; Amy Hauck Newman
Journal:  Bioorg Med Chem       Date:  2006-02-03       Impact factor: 3.641

10.  Dual DAT/sigma1 receptor ligands based on 3-(4-(3-(bis(4-fluorophenyl)amino)propyl)piperazin-1-yl)-1-phenylpropan-1-ol.

Authors:  Jianjing Cao; Theresa Kopajtic; Jonathan L Katz; Amy Hauck Newman
Journal:  Bioorg Med Chem Lett       Date:  2008-08-22       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.